Hyperspectral analysis applied to micro-Brillouin maps of amyloid-beta plaques in Alzheimer's disease brains

被引:23
|
作者
Palombo, Francesca [1 ]
Masia, Francesco [2 ]
Mattana, Sara [3 ]
Tamagnini, Francesco [4 ]
Borri, Paola [5 ]
Langbein, Wolfgang [2 ]
Fioretto, Daniele [6 ]
机构
[1] Univ Exeter, Sch Phys & Astron, Exeter EX4 4QL, Devon, England
[2] Cardiff Univ, Sch Phys & Astron, Cardiff CF24 3AA, S Glam, Wales
[3] CNR, Natl Inst Opt, I-50125 Florence, Italy
[4] Univ Reading, Sch Pharm, Reading RG6 6LA, Berks, England
[5] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales
[6] Univ Perugia, Dept Phys & Geol, I-06100 Perugia, Italy
基金
英国惠康基金;
关键词
SCATTERING; DEPOSITION;
D O I
10.1039/c8an01291a
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A recent investigation on the architecture and chemical composition of amyloid- (A) plaques in ex vivo histological sections of an A-overexpressing transgenic mouse hippocampus has shed light on the infrared light signature of cell-activation related biomarkers of Alzheimer's disease. A correlation was highlighted between the biomechanical properties detected by Brillouin microscopy and the molecular make-up of A plaques provided by FTIR spectroscopic imaging and Raman microscopy (with correlative immunofluorescence imaging) in this animal model of the disease. In the Brillouin spectra of heterogeneous materials such as biomedical samples, peaks are likely the result of multiple contributions, more or less overlaid on a spatial and spectral scale. The ability to disentangle these contributions is very important as it may give access to discrete components that would otherwise be buried within the Brillouin peak envelope. Here, we applied an unsupervised non-negative matrix factorization method to analyse the spontaneous Brillouin microscopy maps of A plaques in transgenic mouse hippocampal sections. The method has already been proven successful in decomposing chemical images and is applied here for the first time to acoustic maps acquired with a Fabry-Perot Brillouin microscope. We extracted and visualised a decrease in tissue rigidity from the core through to the periphery of the plaque, with spatially distinct components that we assigned to specific entities. This work demonstrates that it is possible to reveal the structure and mechanical properties of A plaques, with details visualized by the projection of the mechanical contrast into a few relevant channels.
引用
收藏
页码:6095 / 6102
页数:8
相关论文
共 50 条
  • [1] Soluble Amyloid-beta Aggregates from Human Alzheimer's Disease Brains
    Esparza, Thomas J.
    Wildburger, Norelle C.
    Jiang, Hao
    Gangolli, Mihika
    Cairns, Nigel J.
    Bateman, Randall J.
    Brody, David L.
    SCIENTIFIC REPORTS, 2016, 6
  • [2] Soluble Amyloid-beta Aggregates from Human Alzheimer’s Disease Brains
    Thomas J. Esparza
    Norelle C. Wildburger
    Hao Jiang
    Mihika Gangolli
    Nigel J. Cairns
    Randall J. Bateman
    David L. Brody
    Scientific Reports, 6
  • [3] The effect of iron in MRI and transverse relaxation of amyloid-beta plaques in Alzheimer's disease
    Meadowcroft, Mark D.
    Peters, Douglas G.
    Dewal, Rahul P.
    Connor, James R.
    Yang, Qing X.
    NMR IN BIOMEDICINE, 2015, 28 (03) : 297 - 305
  • [4] Molecular and Therapeutic Targets for Amyloid-beta Plaques in Alzheimer's Disease: A Review Study
    Thomas, Jaya
    Wilson, Samson
    BASIC AND CLINICAL NEUROSCIENCE, 2024, 15 (01) : 1 - 26
  • [5] Presenilins, amyloid-beta and Alzheimer's disease
    Lamb, BT
    NATURE MEDICINE, 1997, 3 (01) : 28 - 29
  • [6] Laser-Induced In-Source Decay Applied to the Determination of Amyloid-Beta in Alzheimer's Brains
    Kelley, Andrea R.
    Perry, George
    Castellani, Rudolph J.
    Bach, Stephan B. H.
    ACS CHEMICAL NEUROSCIENCE, 2016, 7 (03): : 261 - 268
  • [7] Does oxybutynin alter amyloid-beta peptides or plaques in a mouse model of Alzheimer's disease?
    Klausner, AP
    Fletcher, SG
    Yang, SK
    King-Mangard, V
    Neff, PS
    Tuttle, JB
    Steers, WD
    JOURNAL OF UROLOGY, 2005, 173 (04): : 41 - 41
  • [8] Synthesis and evaluation of chalcone derivatives as probes targeting amyloid-beta plaques in alzheimer's disease
    Park, Y.
    Seung, S.
    Hur, M.
    Yang, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S420 - S420
  • [9] Amyloid-beta and Alzheimer's disease: the role of neprilysin-2 in amyloid-beta clearance
    Marr, Robert A.
    Hafez, Daniel M.
    FRONTIERS IN AGING NEUROSCIENCE, 2014, 6
  • [10] Amyloid-beta antibody treatment in Alzheimer's disease
    Stoegmann, Elisabeth
    Schmidt, Reinhold
    WIENER KLINISCHE WOCHENSCHRIFT, 2024,